A randomized clinical trial comparing the efficacy of ramosetron-trimebutine dual therapy vs trimebutine monotherapy in male patients with irritable bowel syndrome with diarrhea (IBS-D)

Rim D. H.; Lee O. Y.; Lee K. N.; Jun D. W.; Lee H. L.; Yoon B. C.; Choi H. S.

首页> 外文期刊>Neurogastroenterology and motility >A randomized clinical trial comparing the efficacy of ramosetron-trimebutine dual therapy vs trimebutine monotherapy in male patients with irritable bowel syndrome with diarrhea (IBS-D)

【24h】

A randomized clinical trial comparing the efficacy of ramosetron-trimebutine dual therapy vs trimebutine monotherapy in male patients with irritable bowel syndrome with diarrhea (IBS-D)

机译：随机临床试验比较雷莫司琼-曲美布汀双重疗法与曲美布汀单一疗法在肠易激综合征腹泻（IBS-D）男性患者中的疗效

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Neurogastroenterology and motility》 |2016年第1期|共2页
作者
Rim D. H.; Lee O. Y.; Lee K. N.; Jun D. W.; Lee H. L.; Yoon B. C.; Choi H. S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. A randomized clinical trial comparing the efficacy of ramosetron-trimebutine dual therapy vs trimebutine monotherapy in male patients with irritable bowel syndrome with diarrhea (IBS-D) [J] . Rim D. H., Lee O. Y., Lee K. N., Neurogastroenterology and motility . 2016,第Suppla1期

机译：随机临床试验比较雷莫司琼-曲美布汀双重疗法与曲美布汀单一疗法在肠易激综合征腹泻（IBS-D）男性患者中的疗效
2. Efficacy of Rifaximin on Bowel Movement Urgency in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D): A Pooled Analysis of 3 Phase 3 Trials [J] . Pimentel Mark, Cash Brooks D., Wolf Ray, The American Journal of Gastroenterology . 2016,第Suppla1期

机译：利福昔明对以腹泻为主的肠易激综合征（IBS-D）患者排便迫切性的功效：3个3期试验的合并分析
3. A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome. [J] . Matsueda K, Harasawa S, Hongo M, Scandinavian journal of gastroenterology. . 2008,第10期

机译：新型5-羟色胺3型受体拮抗剂雷莫司琼对腹泻型肠易激综合征的男性和女性患者的有效性的随机，双盲，安慰剂对照临床试验。
4. The Effects of Wumei Pill on Intestinal Flora and Neurotransmitters in Rats with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) [C] . Xiaojie Ding, Xiling Sun, Xiaofei Yu, International Conference on Biotechnology and Bioengineering . 2019

机译：尿布丸对腹泻的肠道菌群和神经递质的影响（IBS-D）
5. Effects of a Novel AI Mobile App on Symptom Severity in Subjects with Irritable Bowel Syndrome: A Randomized Controlled Trial [D] . Rafferty, Aaron Joseph. 2020

机译：一种新的AI流动应用对肠易激综合征症状严重程度的影响：随机对照试验
6. The Efficacy of Shugan Jianpi Zhixie Therapy for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials [O] . Ya Xiao, Yanyan Liu, Shaohui Huang, -1

机译：疏肝健脾止泻疗法对腹泻型肠易激综合征的疗效：一项随机双盲安慰剂对照试验的荟萃分析
7. Efficacy of adding Luvos® Healing Earth supplementation to mebeverine in improving symptoms and quality of life of patients with diarrhea-predominant irritable bowel syndrome: A randomized clinical trial [O] . Marjan Mokhtare, Mohammadreza Asadipanah, Mansour Bahardoust, 2018

机译：添加Luvos®治疗地球补充对泥质症状和腹泻症状的症状和质量的疗效疗效：随机临床试验

A randomized clinical trial comparing the efficacy of ramosetron-trimebutine dual therapy vs trimebutine monotherapy in male patients with irritable bowel syndrome with diarrhea (IBS-D)

著录项

相似文献

相关主题

期刊订阅